Cargando…
Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834028/ http://dx.doi.org/10.1186/ar1550 |
| _version_ | 1782178523789656064 |
|---|---|
| author | Baraliakos, X Brandt, J Listing, J Sieper, J Braun, J |
| author_facet | Baraliakos, X Brandt, J Listing, J Sieper, J Braun, J |
| author_sort | Baraliakos, X |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2834028 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2005 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28340282010-03-08 Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years Baraliakos, X Brandt, J Listing, J Sieper, J Braun, J Arthritis Res Ther Poster Presentation BioMed Central 2005 2005-02-17 /pmc/articles/PMC2834028/ http://dx.doi.org/10.1186/ar1550 Text en Copyright ©2005 BioMed Central Ltd |
| spellingShingle | Poster Presentation Baraliakos, X Brandt, J Listing, J Sieper, J Braun, J Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| title | Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| title_full | Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| title_fullStr | Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| title_full_unstemmed | Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| title_short | Clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| title_sort | clinical response to the anti-tumor necrosis factor alpha antibody infliximab in patients with ankylosing spondylitis over 3 years |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2834028/ http://dx.doi.org/10.1186/ar1550 |
| work_keys_str_mv | AT baraliakosx clinicalresponsetotheantitumornecrosisfactoralphaantibodyinfliximabinpatientswithankylosingspondylitisover3years AT brandtj clinicalresponsetotheantitumornecrosisfactoralphaantibodyinfliximabinpatientswithankylosingspondylitisover3years AT listingj clinicalresponsetotheantitumornecrosisfactoralphaantibodyinfliximabinpatientswithankylosingspondylitisover3years AT sieperj clinicalresponsetotheantitumornecrosisfactoralphaantibodyinfliximabinpatientswithankylosingspondylitisover3years AT braunj clinicalresponsetotheantitumornecrosisfactoralphaantibodyinfliximabinpatientswithankylosingspondylitisover3years |